TY - JOUR
T1 - A nationwide register-study of healthcare utilisation in the year preceding a colorectal cancer recurrence diagnosis
AU - Rasmussen, Linda Aagaard
AU - Jensen, Henry
AU - Falborg, Alina Zalounina
AU - Iversen, Lene Hjerrild
AU - Vedsted, Peter
N1 - Publisher Copyright:
© 2021 John Wiley & Sons Ltd.
PY - 2021/11
Y1 - 2021/11
N2 - Objective: To analyse healthcare utilisation in colorectal cancer (CRC) survivors in the 12 months preceding a diagnosis of CRC recurrence. Methods: This register-based cohort study included curatively treated survivors of CRC diagnosed in 2008–2018. Survivors with CRC recurrence were matched 1:5 with recurrence-free survivors. We estimated the monthly frequency of healthcare utilisation before the recurrence diagnosis and a corresponding index date assigned to the matched population. A regression model was used to compare healthcare utilisation between groups. Results: We included 3045 survivors with recurrence and 15,225 recurrence-free survivors. At study entry, both groups had on average one contact per month to general practice. Compared with recurrence-free survivors, survivors with recurrence had more contacts to general practice from 10 months before the diagnosis and more haemoglobin measurements from 4 months before the diagnosis. They had more contacts to hospitals and follow-up clinics from 7 months before the diagnosis and more diagnostic investigations from 2 months before the diagnosis. Conclusion: General practitioners have regular contact with CRC survivors and are involved in detecting recurrence. The increased number of contacts in the months before the rise in diagnostic investigations indicates an opportunity to expedite referral to diagnostics and the diagnosis of CRC recurrence.
AB - Objective: To analyse healthcare utilisation in colorectal cancer (CRC) survivors in the 12 months preceding a diagnosis of CRC recurrence. Methods: This register-based cohort study included curatively treated survivors of CRC diagnosed in 2008–2018. Survivors with CRC recurrence were matched 1:5 with recurrence-free survivors. We estimated the monthly frequency of healthcare utilisation before the recurrence diagnosis and a corresponding index date assigned to the matched population. A regression model was used to compare healthcare utilisation between groups. Results: We included 3045 survivors with recurrence and 15,225 recurrence-free survivors. At study entry, both groups had on average one contact per month to general practice. Compared with recurrence-free survivors, survivors with recurrence had more contacts to general practice from 10 months before the diagnosis and more haemoglobin measurements from 4 months before the diagnosis. They had more contacts to hospitals and follow-up clinics from 7 months before the diagnosis and more diagnostic investigations from 2 months before the diagnosis. Conclusion: General practitioners have regular contact with CRC survivors and are involved in detecting recurrence. The increased number of contacts in the months before the rise in diagnostic investigations indicates an opportunity to expedite referral to diagnostics and the diagnosis of CRC recurrence.
KW - colorectal neoplasms
KW - delivery of healthcare
KW - Denmark
KW - general practitioners
KW - neoplasm recurrence
KW - primary health care
UR - http://www.scopus.com/inward/record.url?scp=85110997586&partnerID=8YFLogxK
U2 - 10.1111/ecc.13494
DO - 10.1111/ecc.13494
M3 - Journal article
C2 - 34291857
AN - SCOPUS:85110997586
SN - 0961-5423
VL - 30
JO - European Journal of Cancer Care
JF - European Journal of Cancer Care
IS - 6
M1 - e13494
ER -